Community sources who report "nothing yet" at eight weeks are reporting something consistent with the biology, not a failure
If your provider only said "25 units" without specifying concentration, call them back
Other health factors
How Providers Evaluate Use Case by Case Medical providers evaluate BPC-157 and TB-500 based on individual patient profiles rather than generalized protocols
5-Amino-1MQ is a small-molecule quinolinium compound not a peptide that selectively inhibits nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme involved in the methylation of nicotinamide using S-adenosylmethionine (SAM) as a methyl donor
Treatment with 5-amino-1mq upregulates proliferationrelated genes (Ki67, PCNA), promotes cell cycle progression, and improves cell fusion efficiency to form more multinucleated myotubes, achieving functional levels similar to those of young mice.Additionally, 5-amino-1mq inhibits muscle stem cell apoptosis, reduces oxidative stress damage, and maintains stemness